Strides Shasun has received an approval from the United States Food & Drug Administration (USFDA) for Polyethylene Glycol 3350, Powder for Solution 17 grams/capful and 17 grams/packet (OTC). The US market for Polyethylene Glycol 3350, Powder for Solution (OTC) is approximately USD 260 Million.
The product will be manufactured at company's flagship plant at Bangalore and will be marketed by Strides Pharma Inc in the US Market. The product will be launched in Q4 FY 2017, in line with the OTC procurement cycle in the market. Polyethylene glycol-3350 powder for oral solution is an osmotic laxative that relieves occasional constipation. It works by softening the stool and increasing the frequency of bowel movements by retaining water in the stool.
Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.50 |
| Dr. Reddys Lab | 1220.50 |
| Cipla | 1232.75 |
| Zydus Lifesciences | 927.80 |
| Lupin | 2321.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: